David Miller is Unlearn’s Chief Science Officer, overseeing the clinical, regulatory, methods development and applications functions. He spent 25 years in academic medicine and pharma/biotech before moving to the tech sector. Prior to joining Unlearn, he founded the Biostatistics and Epidemiology group at Alphabet’s Verily. His previous experience includes presentation of clinical and statistical results to FDA advisory panels in support of successful regulatory submissions.